Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study
Bilal M et al
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
Severe acute pancreatitis admitted to intensive care unit: SOFA is superior to Ransons criteria and APACHE II in determining prognosis
An injectable medication used to treat visceral spasms and poor blood circulation was found to contain glass particulate matter
US$ 22.54
US$ 22.99
US$ 20.76
US$ 26.76
US$ 24.59
US$ 26.16
US$ 21.12
